Cargando…
The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
Impaired immunogenicity of COVID-19 vaccinations in inflammatory arthritis (IA) patients results in diminished immunity. However, optimal booster vaccination regimens are still unknown. Therefore, this study aimed to assess the kinetics of humoral and cellular responses in IA patients after the COVI...
Autores principales: | Wroński, Jakub, Jaszczyk, Bożena, Roszkowski, Leszek, Felis-Giemza, Anna, Bonek, Krzysztof, Kornatka, Anna, Plebańczyk, Magdalena, Burakowski, Tomasz, Lisowska, Barbara, Kwiatkowska, Brygida, Maśliński, Włodzimierz, Wisłowska, Małgorzata, Massalska, Magdalena, Kuca-Warnawin, Ewa, Ciechomska, Marzena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052973/ https://www.ncbi.nlm.nih.gov/pubmed/36992329 http://dx.doi.org/10.3390/v15030620 |
Ejemplares similares
-
Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022) -
Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
por: Bonek, Krzysztof, et al.
Publicado: (2022) -
Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
por: Bonek, Krzysztof, et al.
Publicado: (2021) -
Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction
por: Massalska, Magdalena, et al.
Publicado: (2022) -
S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs
por: Roszkowski, Leszek, et al.
Publicado: (2022)